HA Viscosupplementation Market

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

HA Viscosupplementation Market contains market size and forecasts of HA Viscosupplementation in global, including the following market information:

• Global HA Viscosupplementation Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global HA Viscosupplementation Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five HA Viscosupplementation companies in 2021 (%)

The global HA Viscosupplementation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HA Viscosupplementation include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

surveyed the HA Viscosupplementation manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HA Viscosupplementation Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global HA Viscosupplementation Market Segment Percentages, by Type, 2021 (%)

• Single Injection
• Three Injection
• Five Injection

Global HA Viscosupplementation Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global HA Viscosupplementation Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global HA Viscosupplementation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global HA Viscosupplementation Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies HA Viscosupplementation revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies HA Viscosupplementation revenues share in global market, 2021 (%)
• Key companies HA Viscosupplementation sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies HA Viscosupplementation sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Anika Therapeutics
• Seikagaku
• Zimmer Biomet
• Bioventus
• Ferring
• LG Chem
• Freda
• Haohai Biological
• Shanghai Jingfeng